Animal Genetics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

The Animal Genetics Market size is estimated at USD 6.98 billion in 2025, and is expected to reach USD 9.44 billion by 2030, at a CAGR of 6.23% during the forecast period (2025-2030).

This healthy pace reflects sustained demand for high-quality animal protein, wider use of genomic tools, and the rise of precision breeding that blends genomic selection with conventional husbandry. North America remains the largest regional contributor as advanced laboratories, supportive regulation, and early adoption of artificial insemination and genomic testing keep research cycles short and commercial uptake high. Asia-Pacific is catching up fast, supported by expanding herds, government productivity schemes, and a widening network of in-country genotyping centers that lower access costs. Product-wise, live animals still represent the primary revenue stream, yet genetic material-especially frozen semen and embryos-records quicker growth as logistics, cryopreservation, and digital ordering improve. Technology competition centers on artificial insemination for its proven economics, while CRISPR and related gene-editing tools are moving from experimental to commercial scale as regulatory paths clarify. End-user demand is shifting toward veterinary clinics, where genetic diagnostics are becoming routine for both livestock and companion animals

Global Animal Genetics Market Trends and Insights

Demand for high-yielding disease-resistant livestock breeds

Intensifying pressure on food systems has made genetic disease resistance a core productivity lever. Marker-assisted selection now pinpoints resistance loci quickly, and CRISPR-generated PRRS-resistant pigs demonstrate how precision edits can curb costly outbreaks. Buyers also reward antibiotic-free labels, turning resistance traits into clear price premiums. Breeding firms respond by bundling resistance markers with growth and efficiency traits, while governments channel grants toward projects that cut antimicrobial use. Asia-Pacific producers, exposed to dense farm clusters, view resistance as risk insurance, driving regional demand for verified genetics.

Increased adoption of advanced genetic technologies

Falling sequencing costs and high-throughput SNP arrays have opened genomic testing to mid-scale producers. Integrated prediction models now combine genomic, performance, and environmental records, allowing selection for feed efficiency, heat tolerance, and methane mitigation. Dairy programs, for instance, use rumen microbiome-linked SNP panels to raise nutrient absorption efficiency, lowering feed costs and emissions. Public-private partnerships in Europe and North America co-fund reference populations, ensuring long-term data flow that sustains genetic gain.

High cost of genomic sequencing limiting adoption

While sequencing has become cheaper, upfront equipment outlays and per-sample fees still deter smallholders. Beef enterprises, where genetic gains translate more slowly into cash, adopt cautiously. Output-based pricing schemes and state subsidies partially offset costs, yet access remains uneven. This disparity risks widening performance gaps between industrial players and family farms, nudging policy makers to explore shared lab facilities and tiered service packages.

Other drivers and restraints analyzed in the detailed report include:

1. Rapid adoption of sexed-semen technology
2. Growth of companion-animal genetic testing
3. Shortage of skilled geneticists in breeding co-ops

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The live animal segment generated 62.54% of the animal genetics market in 2024, reflecting the persistent premium that commercial buyers place on proven bulls, boars, rams, and breeding stock with validated production records. Breeders invest in on-farm performance testing, show circuit visibility, and digital pedigree platforms to justify animal prices that often exceed USD 50,000 for elite sires. The trade benefits from improved logistics and quarantine hubs that simplify cross-border movement.

Genetic material, though smaller in absolute value, expands faster at a 6.98% CAGR as cryopreservation advances lower shipment risk and digitized ordering portals connect global buyers to diverse germplasm inventories. Embryo vitrification now achieves post-thaw viability above 90%, widening usage among emerging-market dairies that want rapid genetic leaps without importing live cattle. Semen remains the volume leader for its affordability, but premium embryos and DNA libraries create higher-margin niches. End-product diversity and delivery flexibility position genetic material to outpace overall animal genetics market growth through 2030.

Genetic trait-and-performance testing produced 48.15% of animal genetics market revenue in 2024. The service captures granular data on milk yield, carcass quality, feed conversion, and resilience traits, then integrates them with DNA markers to refine selection indices. Cloud-based dashboards now deliver real-time benchmarking to producers, encouraging iterative improvements each breeding cycle. Demand from integrated pork and poultry operations keeps volume high because small gains in feed efficiency compound across millions of head.

DNA typing and parentage testing, forecast at 7.01% CAGR, benefits from plummeting per-sample sequencing costs and the spread of handheld collection kits that mail specimens to central labs overnight. Companion-animal clinics account for a rising share of samples, but livestock players also employ parentage panels to verify pedigree claims and enforce breed-specific health program compliance. Packages that bundle DNA typing with trait testing help laboratories upsell value-added analytics, strengthening their position within the animal genetics market.

The Animal Genetics Market Report Segments by Animals (Poultry, Porcine, and More), by Animal Genetic Testing Services (DNA Typing, Genetic Trait Tests, and More), by Technology (Artificial Insemination (AI), Embryo Transfer (ET) and More), by End User (Breeding Companies, Livestock Producers/Farms and More) and by Geography. The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America remained the largest region, accounting for 37.34% of the animal genetics market share in 2024. Modern laboratory infrastructure, a seasoned AI technician base, and an accommodating regulatory stance reinforce adoption. The FDA's 2025 approval of gene-edited pork signals growing acceptance of precision breeding in the food chain. USDA outlooks project beef, pork, and broiler production to climb 11.1%, 10.0%, and 11.5% respectively by 2034, reinforcing region-wide demand for superior genetics. Universities add further momentum; SubCas9, a compact CRISPR protein discovered in bovine microbiota, promises more targeted edits with fewer off-target risks.

Asia-Pacific is on course for the fastest 7.75% CAGR through 2030. China rolls out national genomic chips for local breeds, while India promotes sexed semen to lift dairy yield per cow. Rising disposable incomes and shifting diets expand demand for meat, eggs, and dairy, prompting investment in genetic upgrades to boost output and cut imports. Public-private partnerships in genomics lower test prices, helping mid-sized farms participate. These efforts collectively push the region's weight in the animal genetics market upward each year of the forecast period.

Europe holds a sizeable position anchored by stringent welfare and sustainability norms that shape breeder strategies. Emphasis lies on balanced selection indices that pair productivity with animal well-being, especially in swine and poultry lines. South America continues to monetize strong pasture resources; Brazil and Argentina see brisk uptake of gene-edited cattle for heat tolerance and hornlessness traits. The Middle East and parts of Africa, though smaller, explore genomics to counter harsh climates and limited feed supplies. Regulatory clarity in Japan and Argentina-where certain gene-edited livestock qualify as non-GMO-could inspire other jurisdictions and smooth cross-border trade in genetic products.

1. Genus
2. Hendrix Genetics
3. Zoetis
4. Topigs Norsvin
5. Cobb-Vantress Inc.
6. Aviagen Group
7. CRV Holding BV
8. Select Sires
9. STgenetics
10. Semex Alliance
11. Alta Genetics
12. Neogen
13. ABS Global Inc.
14. Genex Co-operative Inc.
15. Grimaud Groupe
16. Eurogene AI Services
17. Sexing Technologies
18. Envigo RMS LLC
19. Bovine Elite
20. Nugenomics Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support